recurrent epithelial ovarian cancer
Conditions
Interventions
Platinum hypersensitive group :NA
Platinum sensitive group:NA
Platinum partial sensitive group:NA
Sponsors
Obstetrics and Gynecology Hospital Affiliated to Fudan University
Eligibility
Sex/Gender
Female
Age
18 Years to 80 Years
Inclusion criteria
Inclusion criteria: 1. Diagnosed as recurrent epithelial malignant ovarian tumor through past medical history, clinical manifestations, physical examination, auxiliary examination, pathology, etc.; 2. The previous treatment achieved complete remission; 3. Sufficient tissue samples can be obtained; 4. Sign the informed consent; 5. ECOG 0-1 points.
Exclusion criteria
Exclusion criteria: 1. The patient refuses DNA sequencing examination; 2. The patient refuses to use olaparib maintenance therapy; 3. The patient has contraindications to the use of platinum drugs; 4. The patient is in a life-threatening emergency state; 5. Combined with other malignant diseases; 6. The informed consent cannot be signed due to other reasons, and there is no other guardian agent; 7. Participate in other clinical trials at the same time.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| DNA; | — |
Secondary
| Measure | Time frame |
|---|---|
| Pharmacokinetics;overall survival;Progression-free survival; | — |
Countries
China
Contacts
Public ContactYao Liangqing
Obstetrics and Gynecology Hospital Affiliated to Fudan University
Outcome results
None listed